Clinical Trial Update: DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

View source ↗

Summary

A completed clinical trial update evaluating Crestor (rosuvastatin) in patients with type 2 diabetes mellitus for lowering LDL cholesterol toward new European g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2, Crestor, Rosuvastatin | Status: COMPLETED